Finasteride, a prescription drug for androgenic alopecia, has become the centerpiece of a cultural shift that redefines masculinity and fuels a booming market. Hims & Hers and telehealth platforms now target men in their early 20s, offering the pill as a preventive measure.

The surge in prescriptions—triple between 2017 and 2024—mirrors a rise in digital marketing, with influencers and social‑media ads promoting finasteride as a status symbol. Dermatologists report that patients now seek the drug before visible hair loss, driven by the fear of falling behind peers.

Hair‑transplant surgery, once a luxury costing up to $20,000, has seen a parallel rise in demand, especially in Turkey where the procedure costs roughly $3,000. The industry’s growth is reshaping revenue streams: telehealth firms capture a share of the $10 billion hair‑loss market, while transplant centers diversify services.

These dynamics signal a broader pre‑juvenation trend, where men invest early in aesthetic health. The result: an expanding market for preventive treatments, a shift in consumer expectations, and new regulatory scrutiny over marketing practices.